
New FDNY order sending patients to closest hospital provokes backlash: ‘Stupid — in a word'
A new city Fire Department directive aimed at slashing the rise in 911 response times has provoked a huge backlash, with patients and hospitals claiming it's actually jeopardizing safety instead of being a lifesaver.
FDNY Commissioner Robert Tucker imposed a rule March 12 requiring EMS ambulance crews to transport all patients — whether their condition is life-threatening — to the nearest hospital, not one where the patients have a relationship with their doctor or where they prefer to go.
4 FDNY Commissioner Robert Tucker imposed a rule requiring EMS ambulance crews to transport all patients to the nearest hospital.
AP
The previous directive only required ambulance crews to deliver patients to the closest hospital during severe or life-threatening medical emergencies.
The selection of the hospital is aided by a computer.
In rare instances, an appeal to a tele-FDNY doctor can overturn the computer-aided decision.
The new policy is too rigid and undermines patient safety and care, said Dr. Bret Rudy, executive vice president and chief of hospital operation at NYU Langone Hospital-Brooklyn.
He said that for example, a patient with a broken hip was recently sent to the emergency department of a hospital that didn't have an orthopedic surgeon to perform surgery. NYU Langone's team ended up going to the other hospital to transfer the patient to Langone for surgery.
'This policy does not produce good outcomes. It's going to result in bad outcomes,' Rudy warned to The Post.
'It's putting more patients at risk.'
4 The new policy is too rigid and undermines patient safety and care, said NYU Langone Hospital-Brooklyn's Dr. Bret Rudy.
NYU Langone
The new directive has led to confrontations between patients and ambulance crews, too.
Eli Gottlieb, 84, said he was suffering from kidney failure and that his doctor, who was affiliated with Mt. Sinai Brooklyn, told him to call 911 for an ambulance to take him to the facility.
Gottlieb said he sat in an ambulance for 30 minutes as he haggled with its crew, which was instructed to take him to Maimonides Midwood Community Hospital.
Gottlieb refused to go there, noting that the hospital that treats him, Mt. Sinai Brooklyn, was not much farther away from his home.
The ambulance crew called the FDNY-teledoctor, who overruled the computer dispatch selection and allowed the ambulance crew to send him to Mt. Sinai Brooklyn. Gottlieb said the ordeal wasted precious time.
Asked how he would describe the nearest-hospital-first policy, Gottlieb responded, 'Stupid — in a word.'
4 In rare instances, an appeal to a tele-FDNY doctor can overturn the computer-aided decision.
Matthew McDermott
A woman in Bensonhurst, Brooklyn, also called 911 to transport her grandmother, who had blood in her stool, to NYU Langone-Brooklyn Hospital, which is in Sunset Park.
The woman, who requested anonymity, said her grandmother is Chinese and that she preferred to send grandma to a hospital with more Chinese-speaking staff.
But the paramedic and EMT in the ambulance said they had to take granny to Coney Island Hospital, which was closer.
The family ended up refusing the medical assistance and drove the grandmother to Langone-Brooklyn.
The new ambulance policy has 'created a lot of consternation' in the hospital industry, said Kenneth Raske, CEO of the Greater New York Hospital Association. He said negotiations are ongoing to see if tweaks can be made to the directive.
But FDNY Commissioner Tucker defended the policy during a Post interview, as did the union leader representing paramedics and EMTS on 911 ambulance crews.
Tucker said some hospital officials are not happy that patients are not being steered to their hospitals by the FDNY 911 system.
'That's a business dispute. I'm in the business of saving lives,' Tucker said.
'I don't steer patients. I take them for the most part to the local hospital. We're not the Uber business or Lyft business to take people where they want to go.'
He said transporting patients to the nearest hospital in most instances is 'the right thing to do' so that ambulance crews can more quickly respond to the next 911 call.
4 The previous directive only required ambulance crews to deliver patients to the closest hospital during severe or life-threatening medical emergencies.
Getty Images
The average ambulance response time to life-threatening emergencies jumped more than 34 seconds, from 8 minutes and 14 seconds in 2024 fiscal year to 8 minutes and 48 seconds for the first quarter of the 2025 fiscal year running from July 1 through November, according to the mayor's management report in January.
The FDNY is in discussions with hospital officials over possible tweaks to the policy, but Tucker does not foresee dramatic change.
'It's working,' he said. 'Response times are coming down.'
A patient who is not facing a life-threatening situation can refuse medical assistance and take a private car service or other transport, Tucker noted.
Oren Barzilay, president of FDNY EMS Local 2507 representing FDNY EMS paramedics and EMTS, backed the new 911 directive, repeating many of the points made by Tucker.
He said some patients want to avoid the city's public hospitals.
'People think we're a cab service to take them where they want to go. We take you to the local hospital to be treated,' Barzilay said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Cabarrus County EMS welcomes new therapy dog
CABARRUS COUNTY, N.C. (QUEEN CITY NEWS) — Cabarrus County EMS introduced their newest team member during the June 3 Work Session. 9-month-old Aussiedoodle, Bingo, is training to become a certified therapy dog. He'll support EMS staff facing secondary trauma from opioid overdose calls. His training is funded through opioid settlement dollars, money from a national lawsuit earmarked for related services. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
6 hours ago
- Yahoo
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory
We came across a bullish thesis on Alpha Cognition Inc. Common Stock (ACOG) by anygal on r/investing on Reddit. In this article, we will summarize the bulls' thesis on ACOG. Alpha Cognition Inc. Common Stock (ACOG)'s share was trading at $9.33 as of 30th May. ACOG's forward P/E was 26.88 according to Yahoo Finance. A chemist in a laboratory analyzing data from the various therapeutic tests conducted. Alpha Cognition Inc. (NASDAQ: ACOG) represents a potentially overlooked opportunity in the Alzheimer's treatment space, having recently launched its oral drug, Zunveyl, at the end of March. With a current market cap of $150 million and $45 million in cash, the company is targeting the underserved segment of the Alzheimer's population—specifically, the 50% of patients in long-term care (LTC) not taking any current medications due to severe side effects. Unlike other galantamine-based drugs, Zunveyl significantly slows disease progression and improves short-term memory with a markedly better safety profile—only one serious side-effect case was reported in its Phase 3 trials, versus a 50% rate seen in traditional options. The drug's Medicare coverage further eases affordability, lowering monthly out-of-pocket costs to $30–$190. Initial demand appears promising, with nearly 500 patients starting treatment in the first two weeks of launch. Even a modest 1% market penetration into the LTC segment could yield $135 million in annual revenue, with $67.5 million in net income assuming 50% margins. A 5% penetration would put net income at $675 million, dwarfing the current valuation. Alpha Cognition has also secured a distribution deal with a major Chinese pharmaceutical firm, creating a royalty-based revenue stream in Asia. While the upside is substantial, key risks remain—most notably, the emergence of unforeseen serious side effects post-launch, which could lead to FDA scrutiny or suspension of sales. Still, the market's underreaction and the company's positioning as a safer, effective alternative in a high-need space make ACOG a high-upside, high-conviction bet for risk-tolerant investors. Previously, we have covered ACOG in March 2025 wherein we summarized a by BullishDoctor on Twitter. The user highlighted that Alpha Cognition Inc.'s drug ZUNVEYL addressed the major side effects of existing Alzheimer's treatments, making it highly tolerable and poised for adoption in long-term care facilities, a $2 billion market. The company was pre-revenue but launched in March 2025 with strong physician support, a nearly complete sales force, and promising catalysts like a Phase 4 study and sublingual formulation, projecting breakeven within three years. Since our last coverage, the stock is up 61% as of 30th May. Alpha Cognition Inc. Common Stock (ACOG) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 8 hedge fund portfolios held ACOG at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of ACOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
Experts doubt FBI's claim that crop fungus smuggled by Chinese students is a threat
By Heather Schlitz CHICAGO (Reuters) -A biological sample that a Chinese researcher was accused of smuggling into the United States and that prosecutors cast as a "dangerous biological pathogen" is a common type of fungus already widespread in U.S. crop fields that likely poses little risk to food safety, experts said. On Tuesday, U.S. federal prosecutors accused two Chinese researchers of smuggling samples of the fungus Fusarium graminearum into the U.S., describing it as a potential agricultural terrorism weapon. Yunqing Jian, 33, a researcher at the University of Michigan's Department of Molecular, Cellular and Developmental Biology has been charged in connection with allegations that she helped her boyfriend, Zunyong Liu, 34, smuggle the pathogen into the U.S. However, agriculture experts interviewed by Reuters this week said the fungus has been in the U.S. for more than a century, can be prevented by spraying pesticides, and is only dangerous if ingested regularly and in large quantities. "As a weapon, it would be a pretty ineffective one," said Jessica Rutkoski, a crop sciences professor, wheat breeder and geneticist at the University of Illinois at Urbana-Champaign. Rutkoski and other researchers said extensive testing for the fungus' toxin, widespread use of fungicides and the difficulty of intentionally creating an infection with the pathogen would make it a clumsy weapon. The U.S. Attorney's Office and the FBI declined Reuters' request for comment. Since the 1900s, U.S. farmers have been battling the fungus, which causes Fusarium head blight, usually known as "scab," which often infects wheat, barley and other grains on farms during rainy years. The telltale pink streaks on the grain heads contain a toxic byproduct called vomitoxin, which is tested for and tightly controlled by grain elevators where farmers sell their crops. Constant testing and monitoring means that only negligible amounts of vomitoxin ever make it into the bread, pasta and cookies Americans eat, far below levels that would sicken a human, experts said. "We have a long history of managing epidemics of scab," said Andrew Friskop, professor and plant pathologist at North Dakota State University, noting that farmers have access to many tools to prevent and control the disease. Farmers began regularly spraying their fields with fungicide as early as the 1990s, and researchers have since developed multiple strains of fungus-resistant wheat. Plant experts said that it would be difficult to fully assess the risks posed by the samples without more information on the particular strain. But Rutkoski, whose research involves intentionally contaminating wheat with the fungus, said that she isn't always successful at infecting her test field's wheat with scab. She said the pathogen is difficult to control, and her lab has to strike the right balance of temperature and humidity to create an infection. In federal court in Detroit on Tuesday, Jian was charged with conspiracy to commit offense or to defraud the U.S., smuggling goods into the U.S., false statements and visa fraud. Jian did not comment on the charges, and the lawyer who represented her in court was not immediately available for comment. Liu could not be immediately reached for comment. The court scheduled Jian's bail hearing for June 13.